CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bunch, R. T.
Right arrow Articles by Eastman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bunch, R. T.
Right arrow Articles by Eastman, A.

Cell Growth & Differentiation, Vol 8, Issue 7 779-788, Copyright © 1997 by American Association of Cancer Research


ARTICLES

7-Hydroxystaurosporine (UCN-01) causes redistribution of proliferating cell nuclear antigen and abrogates cisplatin-induced S-phase arrest in Chinese hamster ovary cells

RT Bunch and A Eastman
Department of Pharmacology and Toxicology, Dartmouth Medical School, Hanover, New Hampshire 03755, USA.

A variety of agents, such as caffeine, have been shown to abrogate the DNA damage-dependent G2 checkpoint and enhance cytotoxicity. However, these agents are too toxic for clinical use. We have reported that the potent protein kinase inhibitor 7-hydroxystaurosporine (UCN-01) at nontoxic doses abrogates the G2 arrest caused by the DNA-damaging agent cisplatin. Here, using Chinese hamster ovary cells, we show that cisplatin causes predominantly an S-phase arrest; UCN-01 abrogates this S-phase arrest, causing progression of cells to G2 and, subsequently, apoptotic cell death. In searching for an explanation for this accelerate DNA synthesis, we discovered that UCN-01 caused translocation of proliferating cell nuclear antigen (PCNA) to the detergent-insoluble, DNA-bound fraction. PCNA acts as a sliding clamp for DNA polymerase delta. Sequestering of PCNA by p21waf1/cip1 is required for p53-dependent G1 arrest in damaged cells. However, the S-phase arrest occurs independently of p53 and p21waf1/cip1. Our results suggest that PCNA is also a component of this S-phase checkpoint, despite the fact that CHO cells are defective for p53, and no increase in p21waf1/cip1 was observed. The mechanism by which PCNA is sequestered in the absence of p21waf1/cip1 and the mechanism by which UCN-01 disrupts this sequestration remain to be elucidated.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
P. N. Lara Jr, P. C. Mack, T. Synold, P. Frankel, J. Longmate, P. H. Gumerlock, J. H. Doroshow, and D. R. Gandara
The Cyclin-Dependent Kinase Inhibitor UCN-01 Plus Cisplatin in Advanced Solid Tumors: A California Cancer Consortium Phase I Pharmacokinetic and Molecular Correlative Trial
Clin. Cancer Res., June 15, 2005; 11(12): 4444 - 4450.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. D. Bradshaw, C. S. Matthews, J. Cookson, E.-H. Chew, M. Shah, K. Bailey, A. Monks, E. Harris, A. D. Westwell, G. Wells, et al.
Elucidation of Thioredoxin as a Molecular Target for Antitumor Quinols
Cancer Res., May 1, 2005; 65(9): 3911 - 3919.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. C. Dees, S. D. Baker, S. O'Reilly, M. A. Rudek, S. B. Davidson, C. Aylesworth, K. Elza-Brown, M. A. Carducci, and R. C. Donehower
A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors
Clin. Cancer Res., January 15, 2005; 11(2): 664 - 671.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
H. Miao, J. A. Seiler, and W. C. Burhans
Regulation of Cellular and SV40 Virus Origins of Replication by Chk1-dependent Intrinsic and UVC Radiation-induced Checkpoints
J. Biol. Chem., February 7, 2003; 278(6): 4295 - 4304.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Yu, J. La Rose, H. Zhang, H. Takemura, K. W. Kohn, and Y. Pommier
UCN-01 Inhibits p53 Up-Regulation and Abrogates {gamma}-Radiation-induced G2-M Checkpoint Independently of p53 by Targeting Both of the Checkpoint Kinases, Chk2 and Chk1
Cancer Res., October 15, 2002; 62(20): 5743 - 5748.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. M. Senderowicz
The Cell Cycle as a Target for Cancer Therapy: Basic and Clinical Findings with the Small Molecule Inhibitors Flavopiridol and UCN-01
Oncologist, August 1, 2002; 7(90003): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
E. A. Kohn, N. D. Ruth, M. K. Brown, M. Livingstone, and A. Eastman
Abrogation of the S Phase DNA Damage Checkpoint Results in S Phase Progression or Premature Mitosis Depending on the Concentration of 7-Hydroxystaurosporine and the Kinetics of Cdc25C Activation
J. Biol. Chem., July 19, 2002; 277(29): 26553 - 26564.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
T. Yamauchi, M. J. Keating, and W. Plunkett
UCN-01 (7-Hydroxystaurosporine) Inhibits DNA Repair and Increases Cytotoxicity in Normal Lymphocytes and Chronic Lymphocytic Leukemia Lymphocytes
Mol. Cancer Ther., February 1, 2002; 1(4): 287 - 294.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. A. Shah and G. K. Schwartz
Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy
Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Z. Sever-Chroneos, S. P. Angus, A. F. Fribourg, H. Wan, I. Todorov, K. E. Knudsen, and E. S. Knudsen
Retinoblastoma Tumor Suppressor Protein Signals through Inhibition of Cyclin-Dependent Kinase 2 Activity To Disrupt PCNA Function in S Phase
Mol. Cell. Biol., June 15, 2001; 21(12): 4032 - 4045.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B. Hu, X.-Y. Zhou, X. Wang, Z.-C. Zeng, G. Iliakis, and Y. Wang
The Radioresistance to Killing of A1-5 Cells Derives from Activation of the Chk1 Pathway
J. Biol. Chem., May 25, 2001; 276(21): 17693 - 17698.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
G. W. Xu, C. L. Nutt, M. C. Zlatescu, M. Keeney, I. Chin-Yee, and J. G. Cairncross
Inactivation of p53 Sensitizes U87MG Glioma Cells to 1,3-bis(2-Chloroethyl)-1-nitrosourea
Cancer Res., May 1, 2001; 61(10): 4155 - 4159.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
Z. Shi, A. Azuma, D. Sampath, Y.-X. Li, P. Huang, and W. Plunkett
S-Phase Arrest by Nucleoside Analogues and Abrogation of Survival without Cell Cycle Progression by 7-Hydroxystaurosporine
Cancer Res., February 1, 2001; 61(3): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Harvey, R. Decker, Y. Dai, G. Schaefer, L. Tang, L. Kramer, P. Dent, and S. Grant
Interactions between 2-Fluoroadenine 9-{beta}-D-Arabinofuranoside and the Kinase Inhibitor UCN-01 in Human Leukemia and Lymphoma Cells
Clin. Cancer Res., February 1, 2001; 7(2): 320 - 330.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
W. Voigt, A. Bulankin, T. Muller, C. Schoeber, A. Grothey, C. Hoang-Vu, and H-J. Schmoll
Schedule-dependent Antagonism of Gemcitabine and Cisplatin in Human Anaplastic Thyroid Cancer Cell Lines
Clin. Cancer Res., May 1, 2000; 6(5): 2087 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Jiang and L.-Y. Yang
Cell Cycle Checkpoint Abrogator UCN-01 Inhibits DNA Repair: Association with Attenuation of the Interaction of XPA and ERCC1 Nucleotide Excision Repair Proteins
Cancer Res., September 1, 1999; 59(18): 4529 - 4534.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
B. Hu, X.-Y. Zhou, X. Wang, Z.-C. Zeng, G. Iliakis, and Y. Wang
The Radioresistance to Killing of A1-5 Cells Derives from Activation of the Chk1 Pathway
J. Biol. Chem., May 25, 2001; 276(21): 17693 - 17698.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1997 by the American Association of Cancer Research.